Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOYDSense Breath Glucose Monitoring in Type 2 Diabetes
NCT05207020Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Venous blood glucose measured with COBAS 8000 automatic analyzer at 3 hours, Capillary blood glucose measured with a commercial glucometer at 3 hours and 3 more. Started Dec 2021; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05207020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05207020.